Pneumatic Nebulizers Market: Rapidly Evolving Industry…… COVID-19….
The global pneumatic
nebulizers market size
was valued at USD 490.6 million in 2015
and is expected to reach a value of USD
893.9 million by 2025. The expansion is attributed to the increasing
geriatric population base along with the growing need for home healthcare
portable devices. The introduction of new systems featuring aerosol drug
delivery technology with minimal drug wastage is expected to drive the market growth.
For instance, in May 2013, Parion Sciences in partnership with Cambridge
Consultants developed a technology that delivers tiny saline droplets that
infiltrate deep into the lungs. The trans-nasal pulmonary aerosol delivery
device currently undergoing clinical trial is intended for the treatment of
cystic fibrosis.
With Covid-19 infections rising globally, the
apprehension regarding a shortage of essential life-saving devices and other
essential medical supplies in order to prevent the spread of this pandemic and
provide optimum care to the infected also widens. In addition, till a
pharmacological treatment is developed, ventilators act as a vital treatment
preference for the COVID-19 patients, who may require critical care. Moreover,
there is an urgent need for a rapid acceleration in the manufacturing process
for a wide range of test-kits (antibody tests, self-administered, and others).
The report will account for Covid19 as a key market contributor.
Moreover, with the rising rate of
hospital admissions and the resultant high expenditure, companies are
encouraged to introduce home care devices that enable pre-hospitalization
monitoring. Furthermore, the advent of integrated devices has empowered
patients and physicians to share and access data on a single platform.
For instance, in March 2016, Philips
received 510 (K) clearance for its Care Orchestrator. The cloud-based
technology is a clinical management software, which promotes homecare for sleep
apnea and respiratory care patients. Moreover, the clinical management system
furnishes a single platform combining sleep and respiratory care, providing
informatics and workflow intelligence for patients, providers, and payers.
Some of the major players operating include
Omron Corporation, Philips Healthcare; PARI Pharma GmbH; GE Healthcare; Allied
Healthcare; Becton, Dickinson and Company; Agilent Technologies; Medline
Industries, Inc.; and Briggs Healthcare.
To Request Sample Copy of this report, click the link:
Further Key Findings from the Study Suggest:
·
Vented nebulizers dominated the
product type segment in 2015 owing to their high availability and affordable
cost. Moreover, industry contributors are introducing new solutions that enable
patient data access in one single platform. In November 2015, CareFusion
introduced a new respiratory solution at the American Association for
Respiratory Care Congress.
·
North America is estimated to
dominate the pneumatic nebulizers market in 2015. The introduction of advanced
technological devices and the supportive medical coverage offered in this
region is expected to further fuel market growth. For instance, in March 2015,
Sunovion Pharmaceuticals, Inc. announced the initiation of Phase III clinical
trial for its SUN-101 solution using PARI Pharma’s eFlow nebulizer system for
COPD.
·
Asia Pacific is the fastest
growing market owing to its huge aging population base, increasing focus on
preventive care, and government initiatives promoting technological
innovations. In July 2015, Tribeca Care launched its online healthcare store to
supply homecare respiratory products, wherein prominent medical brands such as
Philips, Omron, Nidek, Karma, ResMed, and Vissco were brought under one roof.
·
Sector players are integrating
healthcare with technology to improve upon the current patient monitoring
devices in the vertical for respiratory diseases. Moreover, increasing
awareness around pre-assessment devices has further accelerated the demand for
pneumatic nebulizers. In June 2016, Philips introduced the Patient Adherence
Management Service at the 2016 SLEEP event to better patient compliance to
sleep therapy.
The
global pneumatic nebulizers market size was valued at USD 490.6 million in 2015
and is projected to grow at a CAGR of 6.2% over the forecast period. The high
growth is attributed to the rising demand for non-invasive methods of drug
delivery, increasing incidence of various respiratory disorders, and the surging
geriatric population.
The
increasing incidence of respiratory diseases is a vital impact rendering factor
supporting the growth of this sector. In 2011, according to the American Lung
Association, around 10 million Americans suffered from chronic bronchitis.
Moreover, the chances of developing chronic bronchitis increases with age as it
was determined that out of those 10 million cases around 70.0% people were
above 65 years of age.
Nebulizers are electrically powered
or battery-operated devices used to administer liquid drug in the form of mist
and aerosol. The increased surface area yields a better drug therapeutic effect
as compared to inhalation therapy.The device is used to treat various
respiratory disorders such as asthma, Chronic Obstructive Pulmonary Disease (COPD), and cystic
fibrosis. Moreover, the increasing application of pneumatic nebulizer as a
method for treatment of diabetes, migraine, and cancer is expected to drive the
demand for pneumatic nebulizers.
Browse Press
Release of this report:
Government
initiatives and organization funding deployed to improve the current treatment
alternatives for respiratory conditions are also expected to result in an
upsurge in the demand for inhalation devices.The American Heart Association
along with National Association for Stock Car Auto Racing (NASCAR) launched a
DRIVE4COPD campaign in 2011. Through this partnership, NASCAR was responsible
for screening around three million NASCAR fans for COPD.
Another
initiative expected to positively influence the market, is the COPD population
screener by the COPD Foundation. Using this screener, Americans citizens who
are 35 years and older are screened for COPD through a five-question test. If
the screener indicates positive results, the individual is advised to visit a
healthcare professional or call the COPD helpline, thereby raising awareness
among the population to enable early intervention.
Grand View Research has segmented the
global pneumatic nebulizers market by type:
Pneumatic Nebulizers Type Outlook (Market revenue in USD
Million, 2014 - 2025)
·
Vented Pneumatic Nebulizer
·
Breath-Actuated Pneumatic
Nebulizer
About Grand View Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies
ensuring relevant and fact-based research across a range of industries, from
technology to chemicals, materials and healthcare.
Comments
Post a Comment